Travere Therapeutics Inc.

Travere Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Travere Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 127.2 M, a 55.63% increase year-over-year.
• Travere Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 488.2 M, a 149.76% increase year-over-year.
• Travere Therapeutics Inc. annual revenue for 2025 was 490.7 M, a 110.45% increase from 2024.
• Travere Therapeutics Inc. annual revenue for 2024 was 233.2 M, a 60.55% increase from 2023.
• Travere Therapeutics Inc. annual revenue for 2023 was 145.2 M, a 32.69% increase from 2022.
• Travere Therapeutics Inc. annual revenue for 2022 was 109.5 M.